THE TEMPORAL HORMESIS OF DRUG THERAPIES
- Putting a block on heart failure deaths. Ahmed, Mohammed // GP: General Practitioner;6/3/2002, p70
Focuses on the benefits of beta-blockers in treating heart failure. Improvement of left ventricular functions; Performance of clinical trials on the effects of carvedilol; Reduction of mortality.
- Two beta blockers: two difference effects on CHF. // Medical Marketing & Media;Jul2001, Vol. 36 Issue 7, p26
Examines the effects of beta blockers on chronic heart failure. Reduction on the risk of death; Decrease of hospitalization costs; Distributor of bucindol drugs.
- Treatment of chronic heart failure with Î² adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Maggioni, A.P.; Sinagra, G.; Opasich, C.; Geraci, E.; Gorini, M.; Gronda, E.; Lucci, D.; Tognoni, G.; Balli, E.; Tavazzi, L. // Heart;Mar2003, Vol. 89 Issue 3, p299
Background: Several large controlled trials have shown that Î² blockers given to patients with heart failure (New York Heart Association functional class II-IV) reduce morbidity and mortality. Despite these impressive results, implementing the use of Î² blockade in clinical practice appears...
- Obstacles to the initiation of Î² blockers for heart failure in a specialised clinic within a district general hospital. Mahmoudi, M.; McDonagh, S.; Poole-Wilson, P.A.; Dubrey, S.W. // Heart;Apr2003, Vol. 89 Issue 4, p442
Examines the obstacles to the initiation of beta blockers for heart failure in a specialized clinic within a district general hospital. Data showing that beta blocker therapy should be used regardless of age, presence of diabetes, renal impairment or concomitant therapy with digitalis,...
- Beta-Blocker Therapy for Chronic Heart Failure. Carter, Chuck // American Family Physician;4/15/2003, Vol. 67 Issue 8, p1793
Discusses the study 'Î’-Blockers in Chronic Heart Failure: Considerations for Selecting an Agent,' by M.L. Kukin, from the November 2002 issue of the journal 'Mayo Clinic Proceedings.'
- Survival of patients aged >70 years on beta blockers. // Age & Ageing;Sep2009, Vol. 38 Issue 5, p501
The article reports on the results of a trial of 272 patients over the age of 70 years with heart failure who were either treated or left untreated with a beta-blocking agent.
- Are we oversubscribing Ã¢ blockers for heart disease? // BMJ: British Medical Journal;10/6/2012, Vol. 345 Issue 7877, p13
The article reports a study in the October 2012 issue of "The Journal of the American Medical Association," which found that the use of Î² blockers is not as useful as once believed for cardiovascular risk except for heart failure or as secondary prevention after a recent myocardial infarction...
- Q/What is the best beta-blocker for systolic heart failure? Hulkower, Stephen; Aiken, Benjamin A.; Stigleman, Sue // Journal of Family Practice;Feb2015, Vol. 64 Issue 2, p122
The article provides an answer to a question of the best beta-blocker for systolic heart failure.
- Registry to track beta-blocker users. // Patient Care;12/15/1998, Vol. 32 Issue 20, p14
Reports on the Coreg Heart Failure Registry's (COHERE) probe into heart failure patients taking the drug carvedilol in North America. Data on the use of beta-blockade with the drug in a patient population; Aims of the COHERE program.